<DOC>
	<DOCNO>NCT01966107</DOCNO>
	<brief_summary>The Objectives study ass safety Aclidinium bromide major adverse cardiovascular event ( MACE ) , assess overall safety Aclidinium bromide ass whether Aclidinium bromide reduces moderate severe COPD exacerbation . This study double-blind , randomize , placebo control , parallel-group study evaluate effect Aclidinium bromide cardiovascular safety COPD exacerbation patient moderate severe COPD , define Global Initiative Chronic Obstructive Lung Disease ( GOLD ) criterion .</brief_summary>
	<brief_title>Evaluate Effect Aclidinium Bromide Long-term Cardiovascular Safety Exacerbations Moderate Very Severe COPD Patients .</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Muscarinic Antagonists</mesh_term>
	<criteria>1 . Male female outpatient ≥ 40 year age 2 . Current former cigarette smoker smoke history least 10 packyears 3 . A diagnosis stable , moderate severe COPD ( GOLD , 2015 ) postbronchodilator FEV &lt; 80 % FEV1/forced vital capacity ( FVC ) ratio &lt; 70 % 4 . Must least one follow 4 criterion : 1 . Documented cerebrovascular disease ( stroke transient ischemic attack , carotid stenosis ) 2 . Documented coronary artery disease ( angina , MI , angioplasty/stent/bypass ) 3 . Documented peripheral vascular disease history claudication 4 . At least 2 follow atherothrombotic risk factor determine PI : 1 . Male ≥ 65 year female ≥ 70 year 2 . Diabetes 3 . Dyslipidemia 4 . Hypertension 5 . Waist circumference inch male ≥ 40 female ≥ 38 inch 6 . Evidence renal dysfunction ( eGFR &lt; 60 ) microalbuminuria ( eGFR base modification diet renal disease [ MDRD ] equation , microalbuminuria define ≥ 30300 mcg/mg creatinine spot urine ≥30 mg creatinine 24hr urine test ) 5 . Maintained stable respiratory medication 2 week prior randomization ( Appendix II ) 6 . Able perform pulmonary function test ( PFT ) maneuver follow study procedure 7 . Women childbearing potential must negative serum βhuman chorionic gonadotropin ( HCG ) pregnancy test Visit 1A practice medically acceptable method contraception . Otherwise , female patient least 1 year postmenopausal , surgically sterile ( defined hysterectomy tubal ligation ) . 8 . Should understand study procedure willing participate study indicate sign ICF 1 . Significant disease COPD cardiovascular disease ( e.g. , metastatic cancer ) , opinion PI , may either put patient risk participation study disease may influence result study patient 's ability participate study 2 . Unstable life threaten cardiovascular disease COPD determine PI 3 . Patients comorbid lung disease asthma , cystic fibrosis , bronchiectasis , interstitial lung disease , pulmonary thromboembolic disease 4 . Planned lung transplant lung volume reduction surgery 5 . Currently treat combination LAMA LABA/ICS therapy . 6 . Malignancy patient undergone resection , radiation therapy chemotherapy within 5 year prior screen . Patients treat basal cell squamous cell ( skin ) carcinoma allow 7 . Respiratory infection COPD exacerbation Screening and/or within 4 week prior screen 8 . Uncontrolled infection result human immunodeficiency virus ( HIV ) and/or active hepatitis 9 . Reported history drug alcohol abuse within past 12 month 10 . History hypersensitivity reaction inhale anticholinergic , sympathomimetic amine , inhaled medication component thereof ( include report paradoxical bronchospasm ) 11 . History acute urinary retention , treatment refractory benign prostatic hyperplasia ( BPH ) , bladder neck obstruction , narrowangle glaucoma ( Note : Patients control , stable BPH exclude ) 12 . Patients unable use multidose DPI pressurize metereddose inhaler 13 . Treatment investigational drug within 30 day ( 6 halflives , whichever long ) Visit 1A 14 . Women pregnant breastfeed 15 . Use prohibit medication list Appendix II 16 . Employee immediate relative employee AstraZeneca , affiliate partner , study center</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>130 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>